Correction: Nanosphere Eyes FDA OK for Plavix Metabolism, Troponin Tests

CFO Roger Moody talked up Nanosphere's test for Plavix metabolism and other tests in the company's pipeline at the Jefferies Global Healthcare Conference.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.